Description
Taylor & Francis Ltd Cancer Biomarkersminimal And Noninvasive Early Diagnosis And Prognosis 2017 Edition by Debmalya Barh, Angelo Carpi, Mukesh Verma
Gleaning information from more than 100 experts in the field of cancer diagnosis, prognosis, and therapy worldwide, Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis determines the significance of clinical validation approaches for several markers. This book examines the use of noninvasive or minimally invasive molecular cancer markers that are under development or currently in use. It deals with a majority of commonly prevalent cancers and can help anyone working in the health-care industry to recommend or develop early diagnostics, at-risk tests, and prognostic biomarkers for various cancers. It explores the practice of determining biomarkers by their characteristics and relative methodologies, and presents the most recent data as well as a number of current and upcoming early diagnostic noninvasive molecular markers for many common cancers. It also considers the sensitivity and specificity of markers, biomarker market, test providers, and patent information.Approximately 30-35 Cancer Specific Noninvasive Molecular Diagnostic Markers in a Single VolumeThe book details the general and technical aspects of noninvasive cancer markers. It covers imaging, cutting-edge molecular technologies for biomarker development, and noninvasive or minimally invasive sources of molecular markers, as well as quality control and ethical issues in cancer biomarker discovery. It also provides a detailed account of brain, head and neck, and oral cancer markers, and provides information on a number of gastrointestinal cancers, lung cancer, and mesothelioma markers. Emphasizes the Importance of Volatile Markers in Early Cancer DiagnosisPresents noninvasive early molecular markers in urological cancersDescribes gynecological and endocrine cancer markers Details noninvasive markers of breast, ovarian, cervical, and thyroid cancers Addresses hematological malignancies Contains information on noninvasive molecular markers in myelodysplastic syndromes, acute myeloid leukemia, Hodgkin's lymphoma, and multiple myelomaProvides comprehensive information on diagnostic and prognostic biomarkers in cutaneous melanomaThis text considers molecular technologies for biomarker development, noninvasive or minimally invasive sources of molecular markers, and quality control and ethical issues in cancer biomarker discovery. Part I General and Technical AspectsQuality Control and Ethical Issues of Cancer Biomarker DiscoveryAnjana Munshi and Vandana SharmaImaging Techniques in Cancer DiagnosisMohamed Abd El-Salam, Sonia Reda, Salwa Lotfi, Tamar Refaat, and Eman El-AbdRole of PET in Cancer DiagnosisSilvia Taralli, Antonella Stefanelli, and Giorgio TregliaInnovative Tools for Early Detection of CancerAli Tiss, Amal Hasan, Abdelkrim Khadir, Mohammed Dehbi, and Said DermimeNoninvasive Nanodiagnostics for CancerSandhiya Selvarajan, Melvin George, and Suresh KumarMitochondrial DNA in Early Cancer Diagnosis and ScreeningMukesh Verma, Neelesh Agarwal, and Mudit VermaCirculating miRNA Biomarkers in Various Solid CancersMartina Redova, Hana Mlcochova, and Ondrej SlabyStem Cell Biomarkers in Early Diagnosis, Prognosis, and Therapy of CancerDipali Dhawan and Harish PadhSalivary Biomarkers in Early Diagnosis and Monitoring of CancerSaroj K Basak and Eri S SrivatsanPart II Brain and Head and Neck CancersBiomarkers for Brain GliomasYusuf IzciNoninvasive Biomarkers in Head and Neck Squamous Cell CarcinomaAnand Kumar, Mumtaz Ahmad Ansari, and Vivek SrivastavaBiological Markers in Oral Squamous Cell CarcinomaMario Perez-Sayans Garcia, Danielle Resende Camisasca, Abel Garcia Garcia, Simone de Queiroz Chaves Lourenco, and Anastasios MarkopoulosPart III Gastrointestinal CancersBiomarkers for Gastric Cancer and the Related Premalignant ConditionsMarcis Leja, Jan Bornschein, Juozas Kupcinskas, and Peter MalfertheinerBiomarkers in Esophageal AdenocarcinomaSimon JW Monkhouse, J Muhlschlegel, and H BarrBiomarkers for Diagnosis and Metastasis of Hepatocellular CarcinomaDengfu Yao, Min Yao, Xiaodi Yan, Li Wang, and Zhizhen DongNoninvasive Early Markers in Gallbladder CancerMumtaz Ahmad Ansari, Ruhi Dixit, and Vijay Kumar ShuklaNoninvasive Early Markers in Pancreatic CancerAleksandra NikolicPart IV Lung Cancer and MesotheliomaNoninvasive Early Markers in Lung CancerMukesh Verma, Debmalya Barh, and Neha JainExhaled Volatile Organic Compounds as Noninvasive Early Molecular Markersin Lung Cancer: Bridging the Gap from Bench to BedsideMeggie Hakim, Ulrike Tisch, Michael Unger, and Hossam HaickPart V Urological CancersNoninvasive Early Molecular Biomarkers in Kidney CancerBrian W Cross, Jonathan Huang, and Viraj A MasterNovel Oncomarkers Used for Earlier Detection of Bladder CarcinomaMiroslava Bilecova-Rabajdova, Peter Urban, Maria Marekova, and Vincent NagyScreening for Prostate Cancer: New Markers and Future AspectsNigel P MurrayPart VI Gynecological and Endocrine CancersEarly Biomarkers in Breast CancerRuchika Kaul-Ghanekar, Snehal Suryavanshi, and Prerna RainaNoninvasive Biomarkers in Ovarian CancerSharon A O'Toole, Eugen Ancuta, Ream Langhe, Dolores J Cahill, Mairead Murphy,Cara Martin, Lynda McEvoy, Cathy Spillane, Orla Sheils, Emmanuel Petricoin,Lance Liotta, and John J O'LearyEarly Markers for Neoplastic Lesions of the Uterine CervixPablo Conesa-ZamoraBiomarkers in Diagnosis of Papillary Thyroid CarcinomaMarisa Canadas-Garre, Nuria Munoz Perez, Jesus Maria Villar del Moral, Jose Antonio Ferron Orihuela, and Jose Manuel Llamas-ElviraBiomolecular Markers for Improving Management of Follicular and MedullaryThyroid CancerUmut Mousa, Cuneyd Anil, Serife Mehlika Isildak, Alptekin Gursoy, and Angelo CarpiPart VII Hematological CancersBiomarkers in Myelodysplastic SyndromeNestor L Lopez Corrales and Vasco Ariston de Carvalho AzevedoMarkers for Diagnosis, Prognosis, and Therapy of Acute Myeloid LeukemiaOta FuchsBiomarkers in Hodgkin's LymphomaEsin Demir, Burak Yilmaz, Mehmet Gunduz, and Esra GunduzMultiple Myeloma and Evolution of Novel Biomarkers and TherapiesMichael Byrne, Joseph Katz, and Jan S MorebPart VIII MelanomaDiagnostic and Prognostic Biomarkers in Cutaneous MelanomaEijun Itakura and Alistair J CochranIndex